Alexion Pharmaceuticals Inc (ALXN) Return on Equity ROE from the first quarter 2021 to first quarter 2020 and annually, average high and low, overall ranking from Mar 31 2021 to Mar 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alexion Pharmaceuticals Inc   (NASDAQ: ALXN)

Alexion Pharmaceuticals Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Alexion Pharmaceuticals Inc in the first quarter 2021?
Alexion Pharmaceuticals Inc achieved a return on average equity (ROE) of 4.69 % in its first quarter 2021, which is below Alexion Pharmaceuticals Inc 's average return on equity, which stands at 10.03%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Major Pharmaceutical Preparations industry 57 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2020 from 1748 to 2017.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Equity Change 5.82 % 3.37 % 6.83 % 3.22 % -
Y / Y Net Income Change -12.27 % -39.73 % 23.63 % - -5.15 %
Net Income (TTM) in Millions 535 603 957 846 2,374
Return On Equity (TTM) 4.69 % 5.37 % 8.58 % 7.71 % 21.8 %
ALXN's Total Ranking # 2017 # 1748 # 1279 # 1359 # 454
Equity (TTM) in Millions 12,431 11,651 11,075 10,491 11,748
Seq. Equity Change 6.69 % 5.2 % 5.57 % -10.7 % 4.22 %
Seq. Net Income Change -8.7 % -7.32 % - - -37.28 %

Back to ALXN Management Effectiveness >> ALXN's 5 Years Annual ROE >> Compare ALXN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 58
Sector # 180
Overall # 2017

Return On Equity Statistics
High Average Low
28.73 %
10.03 %
-1.12 %
(March 31, 2013)   (Jun 30 2018)





ALXN Annual Return On Equity (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Equity in Millions 11,651 11,272 9,165 8,893 8,694
Y / Y Equity Change 3.37 % 22.98 % 3.06 % 2.29 % 5.27 %
Net Income in Millions 603 2,404 78 443 399
Y / Y Net Income Change -74.9 % 2998.32 % -82.49 % 11.1 % 176.34 %
Return On Equity 5.18 % 21.33 % 0.85 % 4.98 % 4.59 %

Back to ALXN Management Effectiveness >> ALXN's 5 Years Annual ROE >> Compare ALXN ROE to its Competitors




Annual Roe Comment
In 2020 ROE decreased compared to the previous year to 5.18 %, due to deterioration of net income.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ALXN's' Return on Equity at Yahoo Finance
ALXN's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ALXN's Competitors
Subscribers only: Roe for Alexion Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Equity for ALXN's Customers




Companies with similar Return On Equity at Mar 31 2021, within Healthcare Sector ROE
Bio techne Corp  12.79 %
Baxter International Inc   12.68 %
Jrsis Health Care Corp  12.67 %
Carlisle Companies Incorporated  12.49 %
Intuitive Surgical Inc   12.48 %
United Therapeutics Corporation  12.27 %
Haemonetics Corporation  12.25 %
Procyon Corporation  12.12 %
Henry Schein Inc   11.97 %
Pfizer Inc  11.90 %
Global Cord Blood Corp  11.78 %
Integra Lifesciences Holdings Corp  11.75 %
National Healthcare Corp  11.43 %
Zynex inc   11.19 %
Steris Plc  11.03 %
Stryker Corp  10.76 %
Utah Medical Products Inc  10.64 %
Electromed Inc   10.36 %
Radnet Inc   10.22 %
Dr Reddy s Laboratories Limited  9.97 %
Minerva Neurosciences Inc   9.93 %
Fonar Corporation  9.64 %
Lhc Group Inc   9.50 %
Pacific Health Care Organization Inc  9.50 %
Atea Pharmaceuticals Inc   9.43 %
Zomedica Corp   9.35 %
Star Equity Holdings Inc   9.33 %
Avantor Inc   8.84 %
Inari Medical Inc   8.69 %
Teleflex Incorporated  8.56 %

Date modified: 2026-09-12T06:12:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.